The TO-O-1002 human trial will soon be started in Thailand, accordingly the investigator meeting was held by TheratOcular Biotek (the Sponsor) before site initiation, in order to effectively discuss and resolve trial-related issues as well as to coordinate the needed logistic support at the site for the trial.